List view / Grid view

Dr Pascaline Lécorché (Vect-Horus)

 

article

The promise of vectors targeting the LDL receptor

In this Q&A, Pascaline Lécorché, Head of Chemical Biology at…

4 June 2024 | By ,

In this Q&A, Pascaline Lécorché, Head of Chemical Biology at Vect-Horus, outlines the potential of RNA interference therapeutics and the challenges of their use in vivo. There are several strategies to overcome these, and why peptide-based vectors targeting the LDL receptor are a promising approach.